Respiratory and Interstitial Lung Disease Research
At Wojskowy Instytut Medyczny Panstwowy Instytut Badawczy in Warsaw, clinical research in respiratory tract diseases focuses on serious lung conditions such as idiopathic pulmonary fibrosis and systemic sclerosis-associated interstitial lung disease. These studies are designed to evaluate new treatment options and better understand their impact on lung function and symptom control.
- Testing potential therapies for progressive lung fibrosis and related breathing problems
- Studying treatment effects in systemic sclerosis with lung involvement
- Assessing whether new approaches can slow decline in lung function
This area reflects a strong interest in improving care for patients with chronic and often hard-to-treat pulmonary disease.
Oncology and Hematology Trials
The site also carries out extensive research in neoplasms, including acute myeloid leukemia, myelodysplastic syndrome, breast cancer, advanced non-small cell lung cancer, and head and neck cancer. These trials are mainly aimed at testing new cancer therapies, improving response rates, and understanding how treatments work in difficult-to-treat disease settings.
- Evaluating novel treatment combinations for advanced solid tumors and blood cancers
- Studying treatment effectiveness in acute myeloid leukemia and high-risk myelodysplastic syndrome
- Exploring new immunotherapy strategies for lung cancer and head and neck cancer
This oncology portfolio shows active work on both early treatment response and longer-term disease control.
Cardiovascular and Stroke Prevention Studies
In cardiovascular diseases, the research includes coronary artery disease, heart failure, and prevention of ischemic stroke after recent cerebrovascular events. These trials are focused on improving diagnosis, reducing complications, and testing therapies that may lower the risk of major cardiovascular outcomes.
- Evaluating new options for patients with heart failure with preserved or mildly reduced ejection fraction
- Studying stroke prevention after transient ischemic attack or acute ischemic stroke
- Assessing diagnostic tools for suspected coronary artery disease
The cardiovascular program combines treatment and diagnostic research to support earlier and more effective care.
Autoimmune and Inflammatory Disease Research
Clinical trials in immune system diseases at this institution cover giant cell arteritis, systemic lupus erythematosus, systemic sclerosis, and ulcerative colitis. The site also conducts research in rare diseases, including ANCA-associated vasculitis, Sjögren’s syndrome, and hereditary angioedema. The main purpose is to compare new therapies with established treatments and to improve control of inflammation, symptoms, and disease activity.
- Comparing treatments for giant cell arteritis to achieve sustained remission
- Testing therapies for systemic lupus erythematosus and systemic sclerosis
- Studying new approaches for ulcerative colitis in patients with active disease
This research supports broader efforts to find safer and more effective long-term management strategies for autoimmune conditions.
Musculoskeletal, Neurologic, and Women’s Health Studies
The site’s trial portfolio also includes musculoskeletal diseases, nervous system diseases, and female urogenital diseases. Research in these areas addresses endometriosis-related pain, multiple sclerosis, and other conditions where better symptom relief, disease control, or treatment tolerance is needed.
- Evaluating new options for endometriosis and pelvic pain relief
- Studying treatment alternatives for multiple sclerosis
- Exploring therapies that may improve quality of life in chronic inflammatory disorders
These studies broaden the research focus beyond major internal medicine specialties and into conditions that strongly affect daily functioning.
Nephrology and Kidney Disease Research
The site conducts clinical trials across a broad range of kidney diseases, from chronic kidney disease to end-stage kidney disease in patients on maintenance dialysis. A significant part of this work concerns glomerular diseases, including nephrotic syndrome, focal segmental glomerulosclerosis, and the rare Alport syndrome.
- Evaluating therapies that reduce the risk of kidney function decline in chronic kidney disease
- Studying reduction of proteinuria in FSGS, Alport syndrome, and other proteinuric kidney diseases
- Comparing treatment regimens and preventing muscle loss in nephrotic syndrome
- Assessing anti-inflammatory treatment in patients with end-stage kidney disease on dialysis
This is an important area for patients with chronic and rare kidney diseases, where access to new therapies may delay the need for renal replacement therapy.
Dermatology and Skin Disease Studies
In dermatology, the site carries out research in chronic inflammatory skin diseases such as moderate to severe atopic dermatitis and hidradenitis suppurativa. Projects also address rare conditions, including pyoderma gangrenosum and alopecia areata, as well as the treatment of skin toxicities associated with cancer therapy.
- Evaluating new therapies, including biologics, in atopic dermatitis
- Studying long-term treatment efficacy in hidradenitis suppurativa
- Assessing treatment aimed at ulcer closure in pyoderma gangrenosum
- Studying topical treatment of rash in patients receiving EGFR inhibitors
This research is particularly relevant for patients whose disease is not adequately controlled by standard treatment.
Ophthalmology and Eye Disease Research
The site’s research profile also includes ophthalmology. Studies cover pharmacological treatment of acquired blepharoptosis with eye drops, as well as projects at the interface of ophthalmology and oncology in uveal melanoma.
- Evaluating efficacy and safety of eye drops in the treatment of acquired ptosis
- Studying new therapies for uveal melanoma
- Exploring less invasive treatment options in eye diseases
This area combines ophthalmic diagnosis and treatment with the multidisciplinary care available at the site.
